Skip to main content

Table 1 Study visit schedule

From: Temperature-controlled laminar airflow in severe asthma for exacerbation reduction (The LASER Trial): study protocol for a randomised controlled trial

  1. iInformed Consent will be sought for the main trial and qualitative studies (during internal pilot and at completion of the follow-up period) at Screening Visit 1
  2. iiPost Randomisation Telephone Review after 1 month (+/- 3 days) to review device usage and check device related technical issues have been addressed
  3. iiiSevere Exacerbation Reporting. Participants will report severe exacerbations to their local trial team as soon as possible throughout the follow-up period
  4. ivSerum Specific IgE only required if Skin Prick Tests not available
  5. vPost-Trial Provision Period refers to treatment with an active TLA device free of charge including filters and technical support over a 4 year period
  6. viAdult Carer / Partner participation in selected cases is entirely optional and will not influence participant’s eligibility for inclusion in the trial
  7. viiInstallation within 10 working days of Randomisation
  8. viiiDevice Exchange / Removal within 10 working days of last study visit or focus group involvement whichever comes last